Members | Market | Warrants | Research | A.I. | Education | AASTOCKS | Products | US Stocks

		Member Service| Live Picks| Top Features| Back Test| Market| Tech Analysis| University| About Tradetrek
		Block Trades | Money Flow | VWAP | Fundamentals | Historical chart walker | Back Test | Stock Code Lookup

HK US Stock ID: Quote Chart News Fundamentals Comment 5-day Forecast 6-month Target

Jun 19, 2025   03:30:19 a.m.

		2006-8-22   01:10:00 p.m. HKT, XFNA HK-listed Dawnrays Pharmaceutical H1 net profit 45.45 mln yuan vs 47.01 mln   HONG KONG (XFN-ASIA) - Dawnrays Pharmaceutical (Holdings) Ltd first-half to June results: Sales - 398.20 mln yuan vs 311.00 mln Opg profit - 48.73 mln yuan vs 49.37 mln Net profit - 45.45 mln yuan vs 47.01 mln EPS - 0.0568 yuan vs 0.0588 Interim div - 0.015 hkd, unchanged (1 usd = 7.8 hkd, 7.97 yuan) roby.lau@xfn.com rl/rc xfnrl/xfnrc MMMM AFN   News Provided by XFNA   Copyright(C) AASTOCKS.com Limited 2000. All rights reserved

Disclaimers | Privacy Policy | Career Opportunities | Contact Us | Help

www.aastocks.com Support Hotline:(852)2186 8685/ (852) 2121 8803 Email: support@aastocks.com Copyright 2000 AASTOCKS.com Ltd. All rights reserved. AASTOCKS.com LIMITED is a SFC registered Investment Advisor.

Note: AASTOCKS.com Ltd endeavors to ensure the accuracy and reliability of the information provided but does not guarantee its accuracy or reliability and accepts no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.